DEAE-rebeccamycin April 12, 2017 DEAE-rebeccamycin Trade Name Orphan Indication Bile duct tumors USA Market Approval USA USA Designation Date 2004-03-01 00:00:00 Sponsor Helsinn Healthcare SA;Via Pian Scairolo, 6912 Pazzallo, Lugano;